---
title: "MintPharma Capital | Biotech & Life Sciences Venture Capital"
description: "MintPharma Capital invests in biotech innovation, backing dynamic companies developing transformative, life-changing therapeutics with deep scientific and regulatory expertise."
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@type": "FinancialService",
    "name": "MintPharma Capital",
    "description": "Biotech and life sciences venture capital fund investing $2-7 million as lead investor in seed and Series A rounds.",
    "areaServed": "United States",
    "address": {
      "@type": "PostalAddress",
      "addressLocality": "Boca Raton",
      "addressRegion": "FL",
      "addressCountry": "US"
    },
    "founder": [
      {
        "@type": "Person",
        "name": "Robert G. Finizio"
      },
      {
        "@type": "Person",
        "name": "David Adams"
      }
    ],
    "knowsAbout": [
      "Biotech venture capital",
      "Life sciences investing",
      "Pharmaceutical development",
      "Medical device investing",
      "Seed and Series A financing"
    ],
    "parentOrganization": {
      "@type": "Organization",
      "name": "Mint12 LLC",
      "url": "https://www.mint12.com"
    }
  }
---

[![MintPharma Capital](/__l5e/assets-v1/1538914d-2de5-4bae-910b-e2516763b401/MintPharmaCapital_LOGO.png)](/)

-   [About Us](/about)
-   [Strategy](/our-strategy)
-   [Portfolio](/our-portfolio)
-   [Team](/our-team)

[Get in Touch](/contact)

# Investing in  
Biotech Innovation 

At MintPharma Capital, we are passionate about investing in biotech innovation. We believe in the transformative power of life-changing therapeutics and are committed to supporting dynamic companies at the forefront of this field.

Investing in biotech innovation can be challenging, but we have the expertise and experience to navigate this complex environment. Our team of experts includes seasoned professionals with deep expertise in biotech, previous CEOs and executives of multiple top tier pharmaceutical companies, politicians and regulatory experts who bring a wealth of knowledge and insights to our investment decisions.

![MintPharma Capital](/__l5e/assets-v1/1538914d-2de5-4bae-910b-e2516763b401/MintPharmaCapital_LOGO.png)

What We Look For

## Investment Criteria

Typical Investment

$2–5 million

Seed or Series A

We often act as the lead investor in seed or Series A rounds.

Development Stage

We focus on very late-stage pre-clinical and early-stage clinical biotech and pharmaceutical companies, where successful outcomes can create significant value.

First-in-Class

We look for new or first-in-class therapies in areas where no FDA-approved treatment currently exists.

Market Opportunity

We prefer large commercial markets with significant unmet need and limited existing treatment options.

Healthcare Economics

We look for opportunities to improve patients’ lives while reducing the overall financial burden on patients and insurers.

Continue

## Our Strategy

[Explore Our Strategy](/our-strategy)

![MintPharma Capital](/__l5e/assets-v1/1538914d-2de5-4bae-910b-e2516763b401/MintPharmaCapital_LOGO.png)

## Explore

-   [Strategy](/our-strategy)
-   [Portfolio](/our-portfolio)
-   [Team](/our-team)

## Connect

-   [Get in Touch](/contact)

© 2026 MintPharma Capital. All rights reserved.

This site is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security.

[Get in Touch](/contact)